Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ATLANTIC BIOTECH, LLC.

NPI: 1407246887 · POMPANO BEACH, FL 33064 · Clinical Medical Laboratory · NPI assigned 01/23/2015

$0.00
Total Medicaid Paid
1,306
Total Claims
981
Beneficiaries
3
Codes Billed
2018-01
First Month
2019-08
Last Month

Provider Details

Authorized OfficialJANDJEL, GORAN (C.O.O.)
NPI Enumeration Date01/23/2015

Related Entities

Other providers sharing the same authorized official: JANDJEL, GORAN

ProviderCityStateTotal Paid
HARRIS COUNTY LABORATORIES, LLC HOUSTON TX $127.44

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 591 $0.00
2019 715 $0.00

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 34 14 $0.00
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 595 487 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 677 480 $0.00